Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

PURPOSE: The aim of this study was to identify and validate novel biomarkers for distinguishing among hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), liver fibrosis/liver cirrhosis (LF/LC) and chronic hepatitis B (CHB). PATIENTS AND METHODS: Transcriptomic sequencing was conducted on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dandan, Zhang, Xiaoxiao, Tang, Yuhui, Guo, Peilin, Ai, Rong, Hou, Mengmeng, Wang, Yiqi, Yuan, Xiwei, Cui, Luyao, Zhang, Yuguo, Zhao, Suxian, Li, Wencong, Wang, Yang, Sun, Xiaoye, Liu, Lingdi, Dong, Shiming, Li, Lu, Zhao, Wen, Nan, Yuemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112460/
https://www.ncbi.nlm.nih.gov/pubmed/35592243
http://dx.doi.org/10.2147/JHC.S357380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112460/
https://www.ncbi.nlm.nih.gov/pubmed/35592243
http://dx.doi.org/10.2147/JHC.S357380

Ejemplares similares